A HEAD-TO-HEAD COMPARISON OF PEGINTERFERON α-2B TREATMENT REGIMENS IN THE TREATMENT OF CHINESE AND SOUTH-EAST ASIAN PATIENTS WITH HBEAG POSITIVE CHRONIC HEPATITIS B

被引：0
|
作者：
Fan, Xiaoling [1 ]
Wang, Yuming [2 ]
Luo, Duande [3 ]
Hou, Jinlin [4 ]
Huang, Zhenfei [5 ]
Zhang, Ye [5 ]
Xu, Dao-Zhen [1 ]
Cheng, Jun [1 ]
机构：
[1] Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China
[2] Third Mil Med Univ PLA, Southwest Hosp, Dept Infect Dis, Chongqing, Peoples R China
[3] Huazhong Univ Sci & Technol, Union Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China
[4] Nanfang Univ, Nanfang Hosp, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China
[5] MSD China, Dept Med, Shanghai, Peoples R China
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
133
引用
收藏
页码：386A / 386A
页数：1
相关论文
共 50 条
  • [31] Long-term follow-up of peginterferon α treatment of HBeAg-positive chronic hepatitis B patients in phase III study of peginterferon α-2b (40kD, Y Shape) (Pegberon)
    Hou, Fengqin
    Shang, Jia
    Zhang, Mingxiang
    Pan, Chen
    Peng, Yan-zhong
    Chen, Shijun
    Zhang, Dazhi
    Zhao, Wei
    Mao, Qian-guo
    Mao, Qing
    Chen, Yongping
    Wang, Maorong
    Yin, Chibiao
    Peng, Jie
    Wang, Hao
    Meng, Qinghua
    Tan, Deming
    Sun, Li
    Wang, Guiqiang
    HEPATOLOGY, 2017, 66 : 502A - 503A
  • [32] Asian patients with HBeAg-negative chronic hepatitis B respond well to peginterferon alfa-2a (40 KD) (PEGASYS®) treatment
    Jia, Ji-Dong
    Piratvisuth, Teerha
    Lau, George K. K.
    Luo, Kang-Xian
    Jin, Rui
    Lu, Zhi-Meng
    Marcellin, Patrick
    Popescu, Matei
    Button, Peter
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A88 - A88
  • [33] Withdrawal flares after treatment with peginterferon alpha-2b alone or in combination with lamivudine in HBeAg-positive chronic hepatitis B
    Buster, E. H. C. J.
    Flink, H. J.
    Hansen, B. E.
    Janssen, H. L. A.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S186 - S186
  • [34] Withdrawal flares after treatment with peginterferon alpha-2b alone or in combination with lamivudine in HBeAg-positive chronic hepatitis B
    Buster, E. H. C. J.
    Flink, H. J.
    Hansen, B. E.
    Schalm, S. W.
    Janssen, H. L. A.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (07) : A37 - A38
  • [35] ON-TREATMENT HBSAG LEVEL AND HBEAG INDEX CAN EARLY PREDICT HBEAG SEROCONVERSION IN CHRONIC HEPATITIS B, HBEAG POSITIVE PATIENTS TREATED WITH PEGINTERFERON ALPHA-2A
    Phisalprapa, Pochamana
    Charatcharoenwitthaya, Phunchai
    Chainuvati, Siwaporn
    Nimanong, Supot
    Prachayakul, Varayu
    Pausawasdi, Nonthalee
    Pongprasobchai, Supot
    Leelakusolvong, Somchai
    Manatsathit, Sathaporn
    Kachintorn, Udom
    Tanwandee, Tawesak
    HEPATOLOGY, 2010, 52 (04) : 526A - 527A
  • [36] On-treatment HBsAg level and HBeAg index can early predict HBeAg seroconversion in chronic hepatitis B, HBeAg positive patients treated with peginterferon alpha-2a
    Phisalprapa, P.
    Charatcharoenwitthaya, P.
    Chainuwatti, S.
    Nimanong, S.
    Pausawasdi, N.
    Prachayakul, V.
    Pongprasobchai, S.
    Udompanthurak, S.
    Leelakusolvong, S.
    Manatsathit, S.
    Kachintorn, U.
    Tanwandee, T.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A94 - A94
  • [37] Improvement of response prediction applying a dynamic modification during treatment with peginterferon in HBeAg-positive chronic hepatitis B patients
    Hansen, Bettina E.
    Chan, Henry Lik-Yuen
    Sonneveld, Milan J.
    Wong, Vincent W.
    Piratvisuth, Teerha
    Janssen, Harry L.
    HEPATOLOGY, 2012, 56 : 377A - 377A
  • [38] Treatment with peginterferon versus interferon in Chinese patients with hepatitis B
    Yu, Hai-bo
    Liu, En-qi
    Lu, She-min
    Zhao, Si-hai
    BIOMEDICINE & PHARMACOTHERAPY, 2010, 64 (08) : 559 - 564
  • [39] Long-term efficacy and safety of peginterferon in the treatment of children with HBeAg-positive chronic hepatitis B
    Liu, Yunhua
    Li, Hui
    Yan, Xiaohui
    Wei, Jia
    JOURNAL OF VIRAL HEPATITIS, 2019, 26 : 69 - 76
  • [40] Role of IL28-B polymorphisms in the treatment of chronic hepatitis B HBeAg-negative patients with peginterferon
    Boglione, Lucio
    Cusato, Jessica
    Allegra, Sarah
    Esposito, Isabella
    Patti, Francesca
    Cariti, Giuseppe
    Di Perri, Giovanni
    D'Avolio, Antonio
    ANTIVIRAL RESEARCH, 2014, 102 : 35 - 43
12345